Mel-18 Acts as a Tumor Suppressor by Repressing Bmi-1 Expression and Down-regulating Akt Activity in Breast Cancer Cells
Open Access
- 1 June 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (11), 5083-5089
- https://doi.org/10.1158/0008-5472.can-06-4368
Abstract
The Bmi-1 oncogene is overexpressed in a number of malignancies including breast cancer. In addition to Bmi-1, mammalian cells also express four other polycomb group (PcG) proteins that are closely related to Bmi-1. Virtually nothing is known about the role of these PcG proteins in oncogenesis. We have recently reported that Mel-18, a Bmi-1–related PcG protein, negatively regulates Bmi-1 expression, and that its expression negatively correlates with Bmi-1 in proliferating and senescing human fibroblasts. Here, we report that the expression of Bmi-1 and Mel-18 inversely correlates in a number of breast cancer cell lines and in a significant number of breast tumor samples. Overexpression of Mel-18 results in repression of Bmi-1 and reduction of the transformed phenotype in malignant breast cancer cells. Furthermore, the repression of Bmi-1 by Mel-18 is accompanied by the reduction of Akt/protein kinase B (PKB) activity in breast cancer cells. Similarly, Bmi-1 knockdown using RNA interference approach results in down-regulation of Akt/PKB activity and reduction in transformed phenotype of MCF7 cells. Importantly, we show that overexpression of constitutively active Akt overrides tumor-suppressive effect of Mel-18 overexpression and the knockdown of Bmi-1 expression. Thus, our studies suggest that Mel-18 and Bmi-1 may regulate the Akt pathway in breast cancer cells, and that Mel-18 functions as a tumor suppressor by repressing the expression of Bmi-1 and consequently down-regulating Akt activity. [Cancer Res 2007;67(11):5083–9]Keywords
Other Versions
This publication has 20 references indexed in Scilit:
- Mel-18, a Polycomb Group Protein, Regulates Cell Proliferation and Senescence via Transcriptional Repression of Bmi-1 and c-Myc OncoproteinsMolecular Biology of the Cell, 2007
- Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancerThe Breast, 2004
- Stem Cells and CancerCell, 2004
- The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteinsCancer Letters, 2004
- EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle ProgressionCell Cycle, 2003
- Control of the Replicative Life Span of Human Fibroblasts by p16 and the Polycomb Protein Bmi-1Molecular and Cellular Biology, 2003
- The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.2002
- Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARFGenes & Development, 1999
- Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements.Proceedings of the National Academy of Sciences, 1990